Evidence map›Paper›PMID 42104208›Full record

ArticleClinical and translational science2026

Feed-Forward Deep Neural Networks Predict Substrate-Specific Effects of Transporter Variants to Explain Drug Response Variability.

Yoomi Park, Yitian Zhou, Ming Xiao, Anne T Nies, Volker M Lauschke

Abstract read
In one paragraph

Article in Clinical and translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yoomi ParkDepartment of Physiology and Pharmacology and Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.ORCID 0000-0003-3070-938X
Yitian ZhouDepartment of Physiology and Pharmacology and Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.ORCID 0000-0003-3066-5444
Ming XiaoDepartment of Information Science and Engineering, Royal Institute of Technology, KTH, Stockholm, Sweden.ORCID 0000-0002-5407-0835
Anne T NiesDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.ORCID 0000-0001-6862-0730
Volker M LauschkeDepartment of Physiology and Pharmacology and Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.ORCID 0000-0002-1140-6204

Funding

Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) EXC 2180-390900677European Research Commission 101137405European Research Commission 101170408National Research Foundation of Korea (NRF) RS-2023-00209528SciLifeLab and Wallenberg National Program for Data-Driven Life Science 006SciLifeLab and Wallenberg National Program for Data-Driven Life Science WASPDDLS22Swedish Research Council 2021-02801Swedish Research Council 2023-03015Swedish Research Council 2024-03401
6 · The paper itself

Abstract

Genetic variants in drug transporter genes shape the interindividual variability in drug response. However, their functional interpretation has remained limited due to the substrate dependence of variant effects. Existing predictors are substrate-agnostic and cannot capture how a single amino acid change differentially affects transport across drugs. Here, we present the substrate-specific effect predictor (SSEP), the first model to predict transporter variant effects in a substrate-dependent manner. SSEP integrates curated in vitro uptake assays with deep mutational scanning data, leveraging multiscale features extracted from modeled variant-substrate complexes. Based on a feed-forward deep neural network architecture, SSEP provides quantitative, substrate-specific activity scores that correlate with experimental uptake data (Spearman's ρ = 0.64) across multiple transporter families (OCT1, MATE, CNT, and OATP) and substrate classes (biguanides, tetraethylammonium, selective serotonin agonists, sympathomimetics and opiates). In benchmarking analyses, SSEP showed higher concordance (Kruskal-Wallis p = 1.11 × 10

Indexed as

Deep LearningMembrane Transport ProteinsNeural Networks, ComputerPharmacogenomic VariantsBenchmarkingHumansMetforminOctamer Transcription Factor-1Organic Cation Transporter 1Substrate SpecificityTreatment Effect HeterogeneityMembrane Transport ProteinsMetforminOctamer Transcription Factor-1Organic Cation Transporter 1POU2F1 protein, humanbiobankdrug transportersmetforminpharmacogenomicsprecision medicine

Identifiers

PMID42104208
PMCPMC13156069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.